Insider Cluster (4 insiders) ·Filed Feb 27, 2026

LRMR

Larimar Therapeutics, Inc.
BULLISH
Impact 8/10
Horizonweeks Processed7mo ago
Insider cluster: 4 insiders, $6.0M total
Actionable Insight ▲ Bullish

This level of concentrated insider buying — especially one transaction over $5M — is rare and typically signals strong conviction in near-term value. Traders should watch for upcoming clinical updates or catalysts that may have prompted this activity.

DirectionBullish
Confidencehigh
Horizonweeks
Final — all horizons settled through T+60d ⚠ clustered
LRMR ▼ -34.65% at T+60d
LONG call ✗ call lost -34.65% · α vs SPY -44.04% · entry $5.31 → $3.47
Entry anchored
Feb 26, 03:59 PM ET
via exchange tick
T+1d
-1.51%
call -1.51% · α -1.56%
$5.23
settled 7mo ago
T+5d
-1.69%
call -1.69% · α +0.29%
$5.22
settled 7mo ago
T+20d
-12.99%
call -12.99% · α -5.44%
$4.62
settled 6mo ago
T+60d
-34.65%
call -34.65% · α -44.04%
$3.47
settled 4mo ago

Price Chart

Loading chart...

Executive Summary

Four insiders at Larimar Therapeutics collectively purchased $6.07 million in shares over a single day at $5 per share, including a major $5.42 million open-market buy by an insider. This represents a strong, coordinated vote of confidence from corporate insiders.

Key Financial Metrics

Direction
buying
Total Value
$6.1M
Insiders
4

Key Facts

  • Insiders purchased a total of $6.07 million in LRMR stock on February 27, 2026.
  • The largest transaction was a $5.42 million open-market purchase of 1,084,010 shares.
  • All transactions were open-market buys (Form 4 code 'P'), indicating direct cash investment.
  • Total insider buying represents approximately 1.34% of the company's $454M market cap — a materially significant level.

Financial Impact

$6.07 million in insider buying at $5/share, equivalent to 1.34% of market capitalization

market sentimentinsider ownershipfloat reduction

Risk Factors

  • Insider purchases do not guarantee positive outcomes — the stock remains high-risk, especially for a biotech with no commercial products.
  • Buying could be based on non-public information that may not materialize as expected.

Market Snapshot

Exchange
Nasdaq

Investment Themes

Biotech & Drug Discovery

Documents Analyzed

This report is based on 1 SEC document filed with EDGAR.

DocumentAccession Number
CONTEXT: Insider Cluster Data (4 trades, 7d window)cluster-LRMR-1772498798624
6 reports for LRMR
Performance horizon
67% Hit rate 2 of 3 directional calls best @ T+60▲ +3.08%May 14, 2026
Filters
Rows
Reports for LRMR — sortable, filterable
TypeNow
May 14, 2026
20w ago
8-K
BULLISH ★ 7/10
$3.89 $4.01▲ +3.08%▼ −0.50%$2.93 (−24.68%)
May 14, 2026
20w ago
Press Release
BULLISH ★ 7/10
$3.89 $4.01▲ +3.08%▼ −0.50%$2.93 (−24.68%)
Mar 19, 2026
28w ago
Press Release
MIXED ★ 7/10
$4.47 $3.59▼ −19.69%▼ −34.03%$2.93 (−34.45%)
Feb 27, 2026
31w ago
8-K
NEUTRAL ★ 5/10
$5.31 $3.47▼ −34.65%▼ −44.04%$2.93 (−44.82%)
Feb 27, 2026
31w ago
Insider Cluster
BULLISH ★ 8/10
$5.31 $3.47▼ −34.65%▼ −44.04%$2.93 (−44.82%)
Feb 27, 2026
31w ago
Insider Cluster
BULLISH ★ 6/10
$5.31 $3.47▼ −34.65%▼ −44.04%$2.93 (−44.82%)
Showing 6 of 6

US Market Status

Market Open — Closes in 33m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access
Report published Mar 3, 2026